EssilorLuxottica's recommendation from UBS has been downgraded from 'buy' to 'neutral', although the price target has been raised from 232 to 248 euros. This suggests a potential upside of around 7% for the company's shares.
UBS acknowledges a positive outlook for EssilorLuxottica, with expected sales acceleration. However, the brokerage has concerns about high valuations and potential risks, such as customs tariffs. UBS advises taking a cautious approach and suggests reassessing the situation regarding EssilorLuxottica.
The firm highlights the importance of being aware of market dynamics that could impact the optics giant's performance in the future.